BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhu X, Fu Z, Chen SY, et al. (2023) Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss. Nature Communications. 14: 2894
Halperin RF, Hegde A, Lang JD, et al. (2021) Improved methods for RNAseq-based alternative splicing analysis. Scientific Reports. 11: 10740
Orlando KA, Douglas AK, Abudu A, et al. (2020) Re-expression of SMARCA4/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism. Elife. 9
Karnezis AN, Chen SY, Chow C, et al. (2020) Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines. Gynecologic Oncology
Soldi R, Ghosh Halder T, Weston A, et al. (2020) The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer. Plos One. 15: e0235705
Ji JX, Cochrane DR, Tessier-Cloutier B, et al. (2020) Arginine depletion therapy with ADI-PEG20 limits tumor growth in argininosuccinate synthase deficient ovarian cancer, including small cell carcinoma of the ovary, hypercalcemic type. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Tischkowitz M, Huang S, Banerjee S, et al. (2020) Small Cell Carcinoma of the Ovary, Hypercalcaemic Type - genetics, new treatment targets and current management guidelines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Gardner HL, Sivaprakasam K, Briones N, et al. (2019) Canine osteosarcoma genome sequencing identifies recurrent mutations in and the histone methyltransferase gene . Communications Biology. 2: 266
Wang Y, Chen SY, Colborne S, et al. (2018) Histone deacetylase inhibitors synergizes with catalytic inhibitors of EZH2 to exhibit anti-tumor activity in small cell carcinoma of the ovary, hypercalcemic type. Molecular Cancer Therapeutics
Lang JD, Hendricks WPD, Orlando KA, et al. (2018) Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multi-kinase inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
See more...